DJIA 17,049.45 -21.77 -0.13%
NASDAQ 4,496.25 -9.61 -0.21%
S&P 500 1,969.25 -8.55 -0.43%
market minute promo

Mallinckrodt plc (NYSE: MNK)

90.80 0.88 (0.98%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MNK $90.80 0.98%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $89.93
Previous Close $89.92
Daily Range $88.80 - $91.38
52-Week Range $41.67 - $91.38
Market Cap $5.3B
P/E Ratio 81.01
Dividend (Yield) $0.00 (0.0%)
Volume 1,230,738
Average Daily Volume 3,394,585
Current FY EPS $4.26

Sector

Industry

Mallinckrodt plc (MNK) Description

Mallinckrodt plc Ordinary Shares Website: http://www.mallinckrodt.com/

News & Commentary

Why I'm Still Avoiding Questcor

A total of seven litigations against Questcor are currently underway. Two of them - the Retrophin litigation and USAO litigation - represent very serious threats to the H.P. Acthar business model.

Catalyst Pharma Closer to Unconscionable Price Hike for Rare-Disease Drug

Pacira Down on Receipt of FDA Warning Letter for Exparel - Analyst Blog

Mallinckrodt (MNK) Hits New Lifetime High Today

Emergent BioSolutions Initiates Pivotal Study on BioThrax - Analyst Blog

Progenics' Azedra Found Positive in Phase II Follow-Up Data - Analyst Blog

Progenics' Azedra Found Positive in Phase II Follow-Up Data - Analyst Blog

Supernus Confirms 2014 Outlook, Epilepsy Products in Focus - Analyst Blog

Mallinckrodt (MNK) Highlighted As Momo Momentum Stock

Impax Rytary FDA Action Date Extended by Three Months - Analyst Blog

Alcobra (ADHD) Worth Watching: Stock Moves 5.1% Higher - Tale of the Tape

Novo Nordisk's Tresiba Effective in Children & Adolescents - Analyst Blog

See More MNK News...